Pages that link to "Q57267021"

The following pages link to Effectiveness of occlusive bedding in the treatment of atopic dermatitis - a placebo-controlled trial of 12 months' duration (Q57267021):

Displaying 31 items.

• House dust mite reduction and avoidance measures for treating eczema (Q24186585) (← links)
• Alternative, Complementary, and Forgotten Remedies for Atopic Dermatitis (Q26800091) (← links)
• The diagnosis and graded therapy of atopic dermatitis (Q27025032) (← links)
• Feather vs. non-feather bedding for asthma (Q34062360) (← links)
• The role of CD30 in atopic disease (Q34291177) (← links)
• Increase in vesicular hand eczema after house dust mite inhalation provocation: a double-blind, placebo-controlled, cross-over study (Q34304670) (← links)
• Non-pharmacologic therapies for atopic dermatitis (Q34359547) (← links)
• What causes worsening of eczema? A systematic review. (Q34557650) (← links)
• Treatment principles of atopic dermatitis (Q34600248) (← links)
• Can we apply clinical studies to real life? Evidence-based recommendations from studies on development of allergic diseases and allergy prevention (Q34612159) (← links)
• Allergy testing in children: why, who, when and how? (Q35161090) (← links)
• Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches (Q35603170) (← links)
• Environmental prevention in atopic eczema dermatitis syndrome (AEDS) and asthma: avoidance of indoor allergens (Q35831636) (← links)
• Atopic dermatitis prevention (Q36466794) (← links)
• Atopic eczema: what's new? (Q36473293) (← links)
• Management of itch in atopic dermatitis (Q36991444) (← links)
• The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis (Q37439358) (← links)
• Evaluation of the adult patient with atopic dermatitis (Q38081993) (← links)
• House dust mite reduction in the management of atopic dermatitis. A critically appraised topic (Q38092907) (← links)
• Sublingual immunotherapy in the treatment of atopic dermatitis: a systematic review using the GRADE system (Q38287567) (← links)
• Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016. (Q38807878) (← links)
• The role of airborne proteins in atopic dermatitis. (Q42217684) (← links)
• Synergistic effect of multiple indoor allergen sources on atopic symptoms in primary school children (Q45178925) (← links)
• Atopic eczema. What has caused the epidemic in industrialised countries and can early intervention modify the natural history of atopic eczema? (Q46436445) (← links)
• The Natural Course of Atopic Dermatitis and the Association with Asthma (Q48003548) (← links)
• Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters. (Q51986876) (← links)
• Atopiclair (Q56990853) (← links)
• Reply (Q57267019) (← links)
• Atopic dermatitis, house-dust mite, and the placebo effect (Q77331498) (← links)
• Atopic dermatitis (Q78805760) (← links)
• In-vitro diagnostic in atopic dermatitis: Options and limitations (Q92875138) (← links)